Gender differences in insulin-like growth factor and bone mineral density association in old age: The rancho Bernardo study

Journal of Bone and Mineral Research

Volumn 13, Issue 8, 1998, Pages 1343-1349

  Barrett Connor, Elizabeth ^a   Goodman Gruen, Deborah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN;

ADULT; AGE; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BONE DENSITY; CALIFORNIA; COHORT STUDIES; DENSITOMETRY, X-RAY; FEMALE; FEMUR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0031829816     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.8.1343     Document Type: Article

References (48)

1. Rosen CJ, Donahue LR, Hunter SJ 1994 Insulin-like growth factors and bone: The osteoporosis connection. Proc Soc Exp Biol Med 206:83-102.
2. Hall K, Brandt J, Enberg G, Fryklund L 1979 Immunoreactive somatomedin A in human serum. J Clin Endocrinol Metabol 48:271-278.
3. McCarthy T, Centrella M, Canalis E 1989 Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 125:2118-2126.
4. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP 1981 Impaired growth hormone secretion in the adult population: Relation to age and adiposity. J Clin Invest 67: 1361-1369.
5. Clemmons D, Van Wyck J 1984 Factors controlling blood concentration of somatomedin. J Clin Endocrinol Metab 13: 113-143.
6. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR 1994 Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: Implications for bone loss with aging. J Clin Endocrinol Metab 78:1011-1016.
7. Hock J, Centrella M, Canalis E 1988 Insulin-like growth factor-I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254-260.
8. Marcelli C, Yates AJ, Mundy GR 1990 In vivo effects of human recombinant transforming growth factor-β on bone turnover in normal mice. J Bone Miner Res 5:1087-1096.
9. Boonen S, Aerssen J, Dequeker J, Nicholson P, Cheng X-G, Lowet G, Verbeke G, Bouilon R 1997 Age-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I: Potential implications for age-related (Type II) osteoporotic fracture occurrence. Calcif Tissue Int 61:173-178.
10. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC 1995 Serum IGF-I is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 10:1218-1224.
11. Ljunghall S, Johansson A, Burman P, Kampe O, Lindh E, Karlsson FA 1992 Low plasma levels of insulin-like growth factor-I (IGF-I) in male patients with idiopathic osteoporosis. J Intern Med 232:59-64.
12. Wüster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R 1993 Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 234:249-255.
13. Rudman D, Drinka PJ, Wilson CR, Mattson DE, Scherman F, Cuisinier MC, Schultz S 1994 Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol 40:653-661.
14. Bennett A, Wahner H, Riggs B, Hintz R 1984 Insulin-like growth factors I and II: Aging and bone density in women. J Clin Endocrinol Metab 59:701-704.
15. Rosen CJ, Morrison AM, Zhou H, Storm D, Hunter SJ, Musgrave K, Chen T, Wei W, Holick MF 1994 Elderly women in northern New England exhibit seasonal changes in bone mass density and calciotropic hormones. Bone Miner 25:83-92.
16. Romagnoli E, Minisola S, Carnevale V, Scarda A, Rosso R, Scarnecchia L, Pacitti MT, Mazzuoli G 1993 Effect of estrogen deficiency on IGF-I plasma levels: Relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53:1-6.
17. Boonen S, Lesaffre E, Dequeker J, Aerssens J, Nijs J, Pelemans W, Bouillon R 1996 Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: Potential implications for the prevention of age-related bone loss. J Am Geriatr Soc 44:1301-1306.
18. Daughaday WH, Mariz IK, Blethen SI 1980 Inhibition of access of bound somatomedin to membrance receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 51:781-788.
19. Anderson DC, Hopper BR, Lasley BL, Yen SSC 1976 A simple method for the assay of eight steroids in small volumes of plasma. Steroids 28:179-196.
20. Tremblay RR, Dube JY 1974 Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10:599-605.
21. Goodman-Gruen D, Barrett-Connor E 1997 Epidemiology of insulin-like growth factor-I in elderly men and women. Am J Epidemiol 145:970-976.
22. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Bengtsson BA 1994 Serum insulin-like growth factor-I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentration of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 41:351-357.
23. Merimee TJ, Russell B, Quinn S, Riley W 1991 Hormone and receptor studies: Relationship to linear growth in childhood and puberty. J Clin Endocrinol Metab 73:1031-1037.
24. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S, Straume M, Iranmanesh A 1995 Differential impact of age, sex hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80:3209-3222.
25. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58.
26. Abbasi AA, Drinka PJ, Mattson DE, Rudman D 1993 Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men. J Am Geriatr Soc 41:975-982.
27. Franz AG, Rabkin MT 1965 Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab 25:1470.
28. Pfeilschifter J, Schcidt-Nave C, Leidig-Bruckner G, Woitge HW, Blum WF, Wuster C, Haack D, Ziegler R 1996 Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 81: 2534-2540.
29. Greendale GA, Edelstein S, Barrett-Connor E 1997 Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study. J Bone Miner Res 12:1833-1843.
30. Simon K, Rosen CJ, Stene M 1991 Relationship of endogenous and exogenous sex steroids to circulating IGF-I and IGFBP-3 in postmenopausal women. Second International Symposium on Insulin-Like Growth Factors/Somatomedins, San Francisco, CA, U.S.A., abstract A18, pp. 88.
31. Zofková I, Kancheva RL 1996 Effect of estrogen status bone regulating hormones. Bone 19:227-232.
32. August GP 1990 Growth and development in the normal infant and child. In: Becker KL (ed.) Principles and Practice of Endocrinology and Metabolism. J.B. Lippincott, Philadelphia, PA, U.S.A., pp. 72-80.
33. LeRoith D, Clemmons D, Nissley P, Rechler MM 1992 Insulin-like growth factors in health and disease. Ann Intern Med 116:854-862.
34. Goodman-Gruen D, Barrett-Connor E 1996 The effect of replacement estrogen on insulin-like growth factor-I in post-menopausal women: The Rancho Bernardo Study. J Clin Endocrinol Metab 81:4268-4271.
35. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KKY 1993 Effects of different oral estrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in postmenopausal women. Clin Endocrinol 39:561-567.
36. Dawson-Hughes B, Stern D, Goldman J, Reichlin S 1986 Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: Effect of physiological estrogen replacment. J Clin Endocrinol Metab 63:424-432.
37. Weissberger AJ, Ho KK, Lazarus L 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381.
38. Bellantoni MF, Harman M, Cho DE, Blackman MR 1991 Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. J Clin Endocrinol Metab 72:172-178.
39. Ho KY, Weissberger AJ 1992 Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 7:821-827.
40. Bautista CM, Mohan S, Baylink DJ 1990 Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. Metabolism 39:96-100.
41. Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ 1992 The 24/25 kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 74:24-27.
42. Sugimoto T, Katsuhito N, Kuribayasi F, Chihara K 1997 Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12:1272-1279.
43. Kassem M, Brixen K, Blum WF, Mosekilde L, Ericksen EF 1994 Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. J Bone Miner Res 9:1365-1370.
44. Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L 1995 Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: A dose response study. J Bone Miner Res 10:1865-1874.
45. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL 1993 Short-term effects of recombinant human insulin-like growth factor-I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-1387.
46. Johansson AG, Lindh E, Ljunghall S 1992 Insulin-like growth factor-I stimulates bone turnover in osteoporosis. Lancet 339: 1619.
47. Grinspoon SK, Baum HBA, Peterson S, Klibanski A 1995 Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96:900-906.
48. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA 1997 Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550-555.